Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
20.07.23
/
50%
€31.22
Target price
20.07.24
€49.32
Performance (%)
-17.26%
End price
21.07.24
€25.83
Summary
This prediction ended on 21.07.24 with a price of €25.83. The prediction for Arrowhead Pharmaceuticals Inc. disappointed with a performance of -17.26%. B__Riley has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 3.269% | 3.269% | 450.018% | 170.592% |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % | 62,27 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % | 85,45 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % | 76,58 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % | 68,71 % |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $55.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von B__Riley gewählte maximale Laufzeit wurde überschritten
Current prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€59.50
22.01.26
22.01.26
€86.40
22.01.27
22.01.27
27.43%
07.08.26
07.08.26
Stopped prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€18.85
14.02.25
14.02.25
€36.16
14.02.26
14.02.26
185.20%
15.02.26
15.02.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.28
12.08.24
12.08.24
€50.31
12.08.25
12.08.25
-28.88%
13.08.25
13.08.25